These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2151575)

  • 1. Effectiveness and safety of etodolac in treatment of rheumatoid arthritis: a multicentre two-months' open study.
    Puccetti L; Soletti A; Petrini G; Remorini E; Zuccotti M; Bazzichi L; Ciompi ML
    Int J Clin Pharmacol Res; 1990; 10(6):347-53. PubMed ID: 2151575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L; Ciompi ML
    Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
    Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Open evaluation of a new anti-inflammatory analgesic drug: etodolac. Report of a clinical trial].
    Russo Frattasi CA; Bevilacqua R
    Clin Ter; 1989 May; 129(4):293-8. PubMed ID: 2527123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.
    del Toro RA; Concepción R
    Clin Ther; 1983; 5(4):436-44. PubMed ID: 6223699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
    D'Hooghe M
    Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Open clinical study on the efficacy and tolerance of acemetacin in rheumatoid arthritis and osteoarthrosis].
    Gospodinoff A; Fiore L; Dardano B; Fiore D; Scapato P
    Clin Ter; 1989 Jul; 130(2):109-13. PubMed ID: 2529083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
    Vetter G; Placchi M; Joubert L
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre double-blind study of the efficacy, safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis.
    Numo R
    Drugs Exp Clin Res; 1990; 16(1):17-27. PubMed ID: 2198156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolerance and efficacy of proglumetacine in patients with rheumatoid arthritis].
    Murelli M; Lignière GC
    Minerva Med; 1984 May; 75(19):1141-5. PubMed ID: 6728264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated safety profile of etodolac in several thousand patients.
    Schattenkirchner M
    Eur J Rheumatol Inflamm; 1990; 10(1):56-65. PubMed ID: 2146132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapy of rheumatoid arthritis and of osteoarthrosis with proglumetacin.
    Bozsóky S; Zahumenszky Z
    Pharmatherapeutica; 1983; 3(5):305-13. PubMed ID: 6844368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose etodolac in rheumatoid arthritis: a review of early studies.
    Spencer-Green G
    J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.